Loading clinical trials...
Loading clinical trials...
The DRAGON PLC Trial - An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) With PVE Alone in Primary Liver Cancers.
Conditions
Interventions
Portal Vein Embolization
Hepatic Vein Embolization
Locations
55
United States
Yale School of Medicine Hospital
New Haven, Connecticut, United States
Rush University Medical Center
Chicago, Illinois, United States
Mayo Clinic
Rochester, Minnesota, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Cleveland Clinic
Cleveland, Ohio, United States
Monash Medical Center
Melbourne, Australia
Start Date
April 1, 2025
Primary Completion Date
November 15, 2032
Completion Date
November 15, 2032
Last Updated
May 15, 2025
NCT04891289
NCT05969860
NCT06503146
NCT07493044
NCT07466602
NCT07486713
Lead Sponsor
Maastricht University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions